Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non–Small-Cell Lung Cancer

  • Fred R. Hirsch
  • , Ramaswamy Govindan
  • , Zanete Zvirbule
  • , Fadi Braiteh
  • , Achim Rittmeyer
  • , Cristóbal Belda-Iniesta
  • , Dolores Isla
  • , Thomas Cosgriff
  • , Michelle Boyer
  • , Masamichi Ueda
  • , See Phan
  • , David R. Gandara

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non–Small-Cell Lung Cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science